GFACX
Price
$74.20
Change
-$0.72 (-0.96%)
Updated
Sep 25 closing price
Net Assets
338.37B
TADAX
Price
$32.65
Change
-$0.22 (-0.67%)
Updated
Sep 25 closing price
Net Assets
2.94B
Interact to see
Advertisement

GFACX vs TADAX

Header iconGFACX vs TADAX Comparison
Open Charts GFACX vs TADAXBanner chart's image
American Funds Growth Fund of Amer C
Price$74.20
Change-$0.72 (-0.96%)
VolumeN/A
Net Assets338.37B
Transamerica US Growth A
Price$32.65
Change-$0.22 (-0.67%)
VolumeN/A
Net Assets2.94B
GFACX vs TADAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. TADAX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and TADAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 338B vs. TADAX (2.94B). GFACX (0.00) and TADAX (0.00) have matching dividends . GFACX was incepted earlier than TADAX: GFACX (25 years) vs TADAX (16 years). GFACX (1.36) is less costly to investors than TADAX (1.03). TADAX is a more actively managed with annual turnover of: 36.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than TADAX: GFACX (250) vs TADAX (1000). GFACX annual gain was more profitable for investors over the last year : 10.71 vs. TADAX (4.08). GFACX return over 5 years is better than : 37.51 vs. TADAX (24.65).
GFACXTADAXGFACX / TADAX
Total Expense Ratio1.361.03132%
Annual Report Gross Expense Ratio1.361.03132%
Fund Existence25 years16 years-
Gain YTD16.37415.333107%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets338B2.94B11,501%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.714.08262%
Returns for 3 years65.2965.51100%
Returns for 5 years37.5124.65152%
Returns for 10 years93.03108.7086%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX2.840.43
+17.84%
CytomX Therapeutics
EPAC39.71-0.75
-1.85%
Enerpac Tool Group Corp
SOLV70.46-1.36
-1.89%
Solventum Corp
BAOS3.26-0.09
-2.69%
Baosheng Media Group Holdings Limited
YTRA1.42-0.08
-5.63%
Yatra Online